Non-invasive biomarkers for early detection of breast cancer
Simple Summary Early diagnosis of breast cancer greatly increases the chance of cure and
survival from the disease. The mammogram is widely used for early detection of breast …
survival from the disease. The mammogram is widely used for early detection of breast …
Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals
Big-data-based edge biomarker is a new concept to characterize disease features based on
biomedical big data in a dynamical and network manner, which also provides alternative …
biomedical big data in a dynamical and network manner, which also provides alternative …
Interferon-γ promotes inflammation and development of T-cell lymphoma in HTLV-1 bZIP factor transgenic mice
Y Mitagami, J Yasunaga, H Kinosada… - PLoS …, 2015 - journals.plos.org
Human T-cell leukemia virus type 1 (HTLV-1) is an etiological agent of several inflammatory
diseases and a T-cell malignancy, adult T-cell leukemia (ATL). HTLV-1 bZIP factor (HBZ) is …
diseases and a T-cell malignancy, adult T-cell leukemia (ATL). HTLV-1 bZIP factor (HBZ) is …
SHON, a novel secreted protein, regulates epithelial–mesenchymal transition through transforming growth factor‐β signaling in human breast cancer cells
The epithelial–mesenchymal transition (EMT) is one of the main mechanisms contributing to
the onset of cancer metastasis, and has proven to be associated with breast cancer …
the onset of cancer metastasis, and has proven to be associated with breast cancer …
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment
TMA Abdel-Fatah, RJ Broom, J Lu, PM Moseley… - British Journal of …, 2019 - nature.com
Background SHON nuclear expression (SHON-Nuc+) was previously reported to predict
clinical outcomes to tamoxifen therapy in ERα+ breast cancer (BC). Herein we determined if …
clinical outcomes to tamoxifen therapy in ERα+ breast cancer (BC). Herein we determined if …
Molecular characterisation of C11orf67 in luminal breast cancer
RMKMM Rashwan - 2016 - research-repository.uwa.edu.au
The recent integration of both genomic and transcriptomic datasets have added a further
dimension to the landscape of breast cancer subty**, defining novel functional subgroups …
dimension to the landscape of breast cancer subty**, defining novel functional subgroups …
[CITATION][C] Understanding the functions of the novel oncogene SHON in breast cancer
B Xu - 2015 - ResearchSpace@ Auckland